U.S. states need to “rally together” to maintain safety measures like social distancing and mask-wearing even as the federal government helps ramp up the production and delivery of vaccines, the White House said on Wednesday.
White House senior adviser Andy Slavitt said the federal government is planning to spend $100 million to help the joint partnership between Merck & Co and rival Johnson & Johnson accelerate vaccine production.
The infusion will help Johnson & Johnson ramp up its production of vaccines, Slavitt said. The company was contracted to deliver 200 million doses to the federal government by the end of May and roughly a billion doses globally by end-2021.
“Over time we believe Merck will be able to double the capacity of Johnson & Johnson,” Slavitt said.
Slavitt said while the increased production is good news, he urged states like Texas to reconsider recent decisions to lift mask mandates and allow businesses to fully open without restrictions.
There are health officials in every state who feel “now is the wrong time to lift the mask mandate,” Slavitt said. “Hopefully, the country will continue to rally together on this front.”
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
